SNC-Lavalin Group Inc., a fully integrated professional services and project management company headquartered in Canada, has been commissioned by US-based firm DexCom Inc., a leader in continuous glucose monitoring systems (CGM) for diabetes management, to help deliver the latter’s major manufacturing facility in Malaysia that will produce CGM systems for the global market. SNC-Lavalin under the agreement will provide project controls and construction management services for DexCom’s facility in Batu Kawan, Penang, alongside other international and local consultants from concept to design, construction and commissioning.
The Batu Kawan facility is DexCom’s first CGM systems manufacturing facility to be built outside of the US. According to SNC-Lavalin, the project is fast-tracked within an 18-month timeframe from construction to completion, covering a facility with an area of 29 acres and 1.75 million square feet of the built-up zone. It comprises state-of-the-art clean-room manufacturing, a warehouse, office building, multi-level car park, and utility building.
SNC-Lavalin serves some of the most reputable brands in the medical and healthcare sector and has a portfolio of medical and healthcare projects in the region. The new facility in Malaysia is in line with its strategy to continue growing its high potential core services business in the Asia Pacific.
(Sources: SNC-Lavalin Group; MarketWatch Inc.; The Star)
